WHO ICTRP trial
Effect of zinc in treatment of nephrotic syndrome
CTRI/2021/04/032706 · Clinical Trials Registry India (CTRI) · Recruiting
Key facts
| Trial ID | CTRI/2021/04/032706 |
|---|---|
| Public title | Effect of zinc in treatment of nephrotic syndrome |
| Scientific title | Zinc therapy in childhood nephrosis |
| Primary sponsor | MLNMedical college Allahabad |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Recruiting |
| Study type | Interventional |
| Countries | India |
| Conditions | Health Condition 1: N049- Nephrotic syndrome with unspecified morphologic changes |
| Interventions | Intervention1: zinc: 20mg (1ml) once daily orally for three months Control Intervention1: multivitamin drops: 1ml once daily orally for three months |
| Registration date | Sep 4, 2021 |
| Target size | 30 |
| Secondary IDs | NIL |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: